Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy

Liu Yuling , Qiao Fuyuan , Liu Haiyi , Liu Dayan

Current Medical Science ›› 2006, Vol. 26 ›› Issue (28) : 350 -352.

PDF
Current Medical Science ›› 2006, Vol. 26 ›› Issue (28) : 350 -352. DOI: 10.1007/BF02829573
Article

Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy

Author information +
History +
PDF

Abstract

In order to observe the effect of ursodeoxycholic acid (UDCA) in the treatment of intrahepatic cholestasis of pregnancy (ICP), 68 patients with ICP were equally divided into treatment group and control group at random. The patients in treatment group were administered with UDCA 300 mg three times every day and those in control group received a combination of 10% glucose, Vitamin C and Inosine. Itching scores, serum ALT and total bile acids (TBA) were measured before, during and after treatment. The results showed that as compared with those before treatment, itching scores, serum ALT and TBA were significantly reduced after treatment (P<0.05). The occurrences of premature labor, fetal asphyxia and meconium staining in amniotic fluid were significantly lower in treatment group than in control group (P<0.05). It was suggested that UDCA was an effective drug in the treatment of ICP.

Keywords

ursodeoxycholic acid / intrahepatic cholestasis / pregnancy / liver function

Cite this article

Download citation ▾
Liu Yuling, Qiao Fuyuan, Liu Haiyi, Liu Dayan. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. Current Medical Science, 2006, 26(28): 350-352 DOI:10.1007/BF02829573

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

PalmaJ, ReyesH, RibaltaJ, et al.. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology, 1992, 15(6): 1043-1047

[2]

PalmaJ, ReyesH, RibaltaJ, et al.. Ursodeoxycholic acid in the treatment of cholestasis pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol, 1997, 27(6): 1022-1028

[3]

GuldutunaS, ZimmerG, ImhofM, et al.. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology, 1993, 17: 599-604

[4]

PaumgartnerG, BeuersU. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology, 2002, 36(2): 525-531

[5]

AiY, LiuS. Camparison of three methods in the treatment of intrahepatic cholestasis of pregrancy. J Pract Obste Gynecol, 2002, 18(1): 20-22

[6]

GermainA M, KatoS, CarvajalJ A, et al.. Bile acids increase response and expression of humane myometrial oxytocin receptor. Am J Obstet Gynecol, 2003, 189(2): 577-582

[7]

SerranoM A, BritesD, LarenaM G, et al.. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol, 1998, 28(5): 829-839

AI Summary AI Mindmap
PDF

90

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/